Disease/Infection News

RSS

New SARS-CoV-2 strain detected in Southern California, USA

By analyzing throat and nose swabs from patients in Southern California, researchers detected a new SARS-CoV-2 strain with mutations in the spike protein. This major finding may explain a surge in the number of cases in the region.

21 Jan 2021

Vitamin D deficiency associated with higher risk of COVID-19 hospitalization

A new study published shows that low levels of vitamin D are associated with a higher risk of COVID-19 hospitalization.

21 Jan 2021

High factor V levels linked to lymphopenia and weakened immunity in severe COVID-19

A new study suggests that factor V, a coagulation factor, is upregulated in a range of white blood cells in severe COVID-19. This increase is linked to the observed coagulopathy, lymphopenia and suppression of adaptive immunity in such patients.

21 Jan 2021

Blood group associated with cardiovascular events in COVID-19 patients

An illuminating new study by scientists at Harvard Medical School, USA, describes the correlation of such conditions with the ABO blood group. The team's findings may help assess the risk of COVID-19 patients for such complications, promoting early diagnosis and underscoring potential needs for preventive and therapeutic care where possible.

21 Jan 2021

ACE2 and furin levels linked to inflammation in smokers with COVID-19

A new study reports the level of ACE2 and furin, two enzymes that are intimately linked to infection with SARS-CoV-2, the causative agent of COVID-19.

21 Jan 2021

Can cancer patients receive urgent care without risk of COVID-19?

A new study describes how a successful application of mitigation techniques to prevent COVID-19 transmission to cancer patients admitted to or attending a healthcare facility might look.

21 Jan 2021

Researchers immunoengineer nanobead system for circulating tumor cell detection

A team of researchers has immunoengineered a nanobead system for the isolation and detection of circulating tumor cells.

21 Jan 2021

Cancer patients have higher risk of severe COVID -19 infection than non-cancer patients

Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, a new study from Penn Medicine published online today in JNCI Cancer Spectrum shows.

21 Jan 2021

Social influence has a large impact on people's adherence to COVID-19 guidelines

New research published in the British Journal of Psychology indicates that social influence has a large impact on people's adherence to COVID-19 guidelines.

21 Jan 2021

Arthritis drug is no better than standard care in improving severe COVID-19 outcomes, shows new trial

Adding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical covid-19 is no better than standard care alone in improving clinical outcomes at 15 days, finds a new trial published by The BMJ today.

20 Jan 2021

Researchers evaluate the accuracy of NEWS2 scoring system for predicting COVID outcomes

In the first systematic large-scale evaluation of the UK National Early Warning Risk Score (NEWS) 2 as a scoring system for predicting severe COVID-19 outcomes in patients, researchers at King's College London have found poor-to-moderate accuracy for identifying patients at risk of being transferred to intensive care units (ICUs) or dying after 14 days of hospitalization.

20 Jan 2021

Busting myths on airborne transmission of SARS-CoV-2

The rapid spread of COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to significant research on the mechanisms of how the virus spreads, which is usually by airborne transmission.

20 Jan 2021

Nearly one third of UK's hospitalized COVID-19 patients readmitted

In a recent medRxiv preprint paper, researchers from the UK discussed how they determined organ impairment rates post recovery from COVID-19-related hospitalization and compared the results with that in a control group.

20 Jan 2021

Prioritizing vaccination of high-risk individuals has only a marginal effect, study suggests

The World Health Organization reports that as of January 19, 2021, there are approximately 94 million cases of COVID-19 globally, with over 2 million deaths.

20 Jan 2021

People with problems in the upper GI tract may be vulnerable to COVID-19 infection

No evidence so far indicates that food or drinks can transmit the virus that causes COVID-19, but new research at Washington University School of Medicine in St. Louis suggests that people with problems in the upper gastrointestinal (GI) tract may be vulnerable to infection after swallowing the virus.

20 Jan 2021

COVID-19 has transformed the world of vaccines

Researchers at GlaxoSmithKline (GSK) in Italy and Belgium say the coronavirus disease 2019 (COVID-19) pandemic is transforming the world of vaccinology by accelerating vaccine development and the availability of powerful technologies.

20 Jan 2021

South African SARS-CoV-2 variant escapes antibody neutralization

Researchers in South Africa have conducted a study showing that the novel 501Y.V2 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has emerged in the country is able to escape the neutralizing antibodies that are elicited by previously circulating strains of the virus.

20 Jan 2021

Mask-wearing together with social distancing has maximum impact on COVID-19, study finds

A recent study published in the journal The Lancet has revealed that self-reported use of face masks together with social distancing has a considerable impact on controlling the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States.

20 Jan 2021

Ethacrynic acid, a diuretic drug with potential anti-SARS-CoV-2 activity

A study published recently in the journal Viruses has identified a potent diuretic ethacrynic acid as an efficient inhibitor of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This drug can be potentially repurposed to treat coronavirus disease 2019 (COVID-19).

20 Jan 2021

How does SARS-CoV-2 infect brain cells?

Researchers from the University of California San Francisco, Gladstone Institutes in the USA, and The Aga Khan University in Pakistan investigated if human neural cells can be infected by SARS-CoV-2.

20 Jan 2021

Disease/Infection News

New SARS-CoV-2 strain detected in Southern California, USA

Vitamin D deficiency associated with higher risk of COVID-19 hospitalization

High factor V levels linked to lymphopenia and weakened immunity in severe COVID-19

Blood group associated with cardiovascular events in COVID-19 patients

ACE2 and furin levels linked to inflammation in smokers with COVID-19

Can cancer patients receive urgent care without risk of COVID-19?

Researchers immunoengineer nanobead system for circulating tumor cell detection

Cancer patients have higher risk of severe COVID -19 infection than non-cancer patients

Social influence has a large impact on people's adherence to COVID-19 guidelines

Arthritis drug is no better than standard care in improving severe COVID-19 outcomes, shows new trial

Researchers evaluate the accuracy of NEWS2 scoring system for predicting COVID outcomes

Busting myths on airborne transmission of SARS-CoV-2

Nearly one third of UK's hospitalized COVID-19 patients readmitted

Prioritizing vaccination of high-risk individuals has only a marginal effect, study suggests

People with problems in the upper GI tract may be vulnerable to COVID-19 infection

COVID-19 has transformed the world of vaccines

South African SARS-CoV-2 variant escapes antibody neutralization

Mask-wearing together with social distancing has maximum impact on COVID-19, study finds

Ethacrynic acid, a diuretic drug with potential anti-SARS-CoV-2 activity

How does SARS-CoV-2 infect brain cells?

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News